We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
-28.74%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$790M
AUM Growth
-$334M
Cap. Flow
+$86M
Cap. Flow %
10.89%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$96.4M
2
VRAY
ViewRay, Inc.
VRAY
+$36.9M

Top Sells

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$39.8M
2
SMG icon
ScottsMiracle-Gro
SMG
+$7.48M

Sector Composition

Rank Sector Weight
1 Financials 54.07%
2 Industrials 21.52%
3 Healthcare 8.4%
4 Technology 6.05%
5 Materials 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DB icon
1
Deutsche Bank
DB
$66.3B
$427M 54.07%
64,861,476
– –
CATM
2
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$170M 21.52%
8,126,933
– –
TVTY
3
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$55.1M 6.97%
8,755,310
+5,973,655
+215% +$96.4M
CTLP
4
DELISTED
Cantaloupe
CTLP
$47.8M 6.05%
10,385,172
– –
VRAY
5
DELISTED
ViewRay, Inc.
VRAY
$32.6M 4.12%
+13,024,684
New +$36.9M
SMG icon
6
ScottsMiracle-Gro
SMG
$4.03B
$29.9M 3.79%
292,237
-68,038
-19% -$7.48M
STOR
7
DELISTED
STORE Capital Corporation
STOR
$16.1M 2.04%
890,800
– –
NTRA icon
8
Natera
NTRA
$37.5B
$11.3M 1.43%
378,589
– –
EGRX
9
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-661,897
Closed -$39.8M

Similar funds

SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $151M AUM 14.38% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
BA
Brightwater Advisory Tampa, Florida $151M AUM 17.08% 1-Year Est. Return

Hudson Executive Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Hudson Executive Capital held 9 positions worth $790M, down 30% from $1.12B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital deployed $86M of net new capital in Q1 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was ViewRay, Inc.: 13,024,684 shares worth $32.6M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, up from 45% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was ScottsMiracle-Gro, an estimated $7.48M trimmed.

  • Hudson Executive Capital's largest Q1 2020 buy was ViewRay, Inc.: 13,024,684 shares worth $32.6M.
  • Hudson Executive Capital added most to Tivity Health, Inc. Common Stock in Q1 2020, an estimated $96.4M increase.
  • Hudson Executive Capital's biggest Q1 2020 reduction was ScottsMiracle-Gro, cutting an estimated $7.48M.
  • Hudson Executive Capital fully exited Eagle Pharmaceuticals, Inc. in Q1 2020, selling an estimated $39.8M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $790M portfolio in Q1 2020.
  • Hudson Executive Capital opened 1 new position and closed 1 in Q1 2020.
  • Hudson Executive Capital's portfolio value fell 30% quarter-over-quarter to $790M.

Based on Hudson Executive Capital's 13F filing for Q1 2020, filed 15 May 2020.